RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
MASSAIA M
Collezione AO Ordine Mauriziano
Items : 8
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.
2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
ASL Cuneo 1
AOU Novara
Fazi P; Vignetti M; Piciocchi A; Cuneo A; Foà R; Guarini A; Nanni M; Neri A; De Propris MS; De Novi LA; Visentin A; Vitale C; Albano F; Molinari MC; Pietrasanta D; Mattiello V; Liberati AM; Giordano A; Gottardi D; Patrizi VB; Galieni P; Musuraca G; Deodato M; Arcari A; Tani M; Levato L; Marchetti M; Massaia M; Rigolin GM; et alii...
ADAMTS13 Autoantibodies and Burden of Care in Immune Thrombotic Thrombocytopenic purpura: New Evidence and Future Implications. in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis / Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221125785. doi: 10.1177/10760296221125785.
2022
AOU Città della Salute di Torino
AO Cuneo
AO Ordine Mauriziano
Borchiellini A; Pizzo E; Valpreda A; Sivera P; Montaruli B; Porreca A; Massaia M; Bruno B; Dainese C; Valeri F;
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. in Oncoimmunology / Oncoimmunology. 2018 Feb 8;7(4):e1341032. doi: 10.1080/2162402X.2017.1341032. eCollection 2018.
2018
AO Ordine Mauriziano
Circosta P; Elia AR; Landra I; Machiorlatti R; Todaro M; Aliberti S; Brusa D; Deaglio S; Chiaretti S; Bruna R; Gottardi D; Massaia M; Giacomo FD; Guarini AR; Foà R; Kyriakides PW; Bareja R; Elemento O; Chichili GR; Monteleone E; Moore PA; Johnson S; Bonvini E; Cignetti A; Inghirami G;
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. in Haematologica / Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8.
2017
AO Ordine Mauriziano
AOU Città della Salute di Torino
AO Cuneo
Piciocchi A; Boncompagni R; Orlando S; Cuneo A; Galieni P; Marasca R; Vannata B; Pozzato G; Efremov DG; Molica S; Coscia M; Massaia M; D'Arena G; Del Poeta G; Mannina D; Mauro FR; Ciolli S; Autore F; Innocenti I; Laurenti L; Vincelli D; Liberati AM; Russo F; Foá R;
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). in Leukemia & lymphoma / Leuk Lymphoma. 2016;57(6):1256-68. doi: 10.3109/10428194.2015.1131278. Epub 2016 Jan 6.
2016
AOU Alessandria
AO Ordine Mauriziano
Schönland S; Palumbo A; Morris C; Massaia M; Lemoli RM; Ladetto M; Festuccia M; Garderet L; Gahrton G; Auner HW; Bruno B; Boccadoro M; Kröger N;
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells. in Oncotarget / Oncotarget. 2015 Oct 6;6(30):29833-46. doi: 10.18632/oncotarget.4006.
2015
AO Ordine Mauriziano
AOU Città della Salute di Torino
Rigoni M; Riganti C; Vitale C; Griggio V; Campia I; Robino M; Foglietta M; Castella B; Sciancalepore P; Buondonno I; Drandi D; Ladetto M; Boccadoro M; Massaia M; Coscia M;
2015
AO Ordine Mauriziano
ASL Asti
Griggio V; Vitale C; Riganti C; Kopecka J; Dal Bo M; Rossi D; Pozzato G; Laurenti L; Zallio F; Marchetti M; Ruggeri M; Omedè P; Del Poeta G; Gattei V; Gaidano G; Boccadoro M; Massaia M; Coscia M;
2015
AO Ordine Mauriziano
Laurenti L; Autore F; Innocenti I; Vannata B; Ciolli S; Mauro FR; Mannina D; Del Poeta G; D'Arena G; Massaia M; Coscia M; Molica S; Pozzato G; Marasca R; Galieni P; Cuneo A; Orlando S; Piciocchi A; Boncompagni R; Vincelli D; Liberati AM; Russo F; Foà R;